Concepedia
Statistics
Publications
1
Citations
10
H-Index
Active since
2008
Hal Mann is an author specializing in ret signaling, ret inhibitors, and oncology.
Publications per year
2008–2008
Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
John V. Heymach, Emer O. Hanrahan, Hal Mann et al. · Journal of Clinical Oncology · 2008 · 10 citations
Medicine, Oncology, Pharmacology +14
1–1 of 1